Bloomage Biotechnology Corp Ltd Net Asset Quality Index
Bloomage Biotechnology Corp Ltd net asset quality index. Bloomage Biotechnology Corp Ltd (688363) has a Net Asset Quality Index of 81.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥8.75 Billion minus total liabilities of CN¥1.59 Billion yields net assets of CN¥7.16 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Bloomage Biotechnology Corp Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Bloomage Biotechnology Corp Ltd (2012–2025)
Net asset quality index of Bloomage Biotechnology Corp Ltd from 2012 to 2025. This chart shows how Bloomage Biotechnology Corp Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 81.8%, representing net assets of CN¥7.16 Billion against total assets of CN¥8.75 Billion CNY. See Bloomage Biotechnology Corp Ltd shareholders equity for net asset value and shareholders' equity analysis.
Bloomage Biotechnology Corp Ltd Net Asset Quality Index by Year (2012–2025)
Bloomage Biotechnology Corp Ltd net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Bloomage Biotechnology Corp Ltd from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Bloomage Biotechnology Corp Ltd market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.9% | CN¥7.12 Billion | CN¥8.69 Billion | CN¥1.58 Billion | ▲ +2.8 pp |
| 2024 | 79.0% | CN¥6.84 Billion | CN¥8.66 Billion | CN¥1.82 Billion | ▼ -3.4 pp |
| 2023 | 82.4% | CN¥6.98 Billion | CN¥8.47 Billion | CN¥1.49 Billion | ▲ +5.5 pp |
| 2022 | 77.0% | CN¥6.68 Billion | CN¥8.68 Billion | CN¥2.00 Billion | ▲ +1.0 pp |
| 2021 | 76.0% | CN¥5.70 Billion | CN¥7.50 Billion | CN¥1.80 Billion | ▼ -13.1 pp |
| 2020 | 89.1% | CN¥5.09 Billion | CN¥5.72 Billion | CN¥622.68 Million | ▼ -2.4 pp |
| 2019 | 91.5% | CN¥4.55 Billion | CN¥4.97 Billion | CN¥422.11 Million | ▲ +8.6 pp |
| 2018 | 82.9% | CN¥1.72 Billion | CN¥2.07 Billion | CN¥353.56 Million | ▼ -4.0 pp |
| 2017 | 87.0% | CN¥1.64 Billion | CN¥1.88 Billion | CN¥245.35 Million | ▲ +12.1 pp |
| 2016 | 74.9% | CN¥1.26 Billion | CN¥1.68 Billion | CN¥423.53 Million | ▲ +20.7 pp |
| 2015 | 54.2% | CN¥1.19 Billion | CN¥2.20 Billion | CN¥1.01 Billion | ▼ -23.7 pp |
| 2014 | 77.9% | CN¥752.51 Million | CN¥965.44 Million | CN¥212.94 Million | ▲ +4.5 pp |
| 2013 | 73.5% | CN¥564.35 Million | CN¥768.31 Million | CN¥203.96 Million | ▼ -6.0 pp |
| 2012 | 79.5% | CN¥376.97 Million | CN¥474.26 Million | CN¥97.29 Million | — |